Laura Benjamin

Laura Benjamin

Company: Oncxerna

Job title: Chief Executive Officer


Identifying Predictive Biomarkers for Immuno-Oncology Therapeutics 3:00 pm

• Given the large number of novel IO agents and combination clinical trials being run, what is needed to harmonize biomarkers for the medical community? • Where is progress being made in developing analytically and clinically validated assays? • What impact does new predictive biomarker identification have on commercial potential of novel therapeutics?Read more

day: Track A - Day 1 pm

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.